Palomar Q4 adjusted EPS beats estimates

Reuters
02/12
Palomar Q4 adjusted EPS beats estimates

Overview

  • Specialty insurer's Q4 adjusted EPS beat analyst expectations

  • Adjusted net income for Q4 beat consensus

  • Company's gross written premiums rose 31.8% yr/yr

Outlook

  • Company expects full-year 2026 adjusted net income between $260 mln and $275 mln

  • Company estimates $8 mln to $12 mln in catastrophe losses for 2026

Result Drivers

  • PREMIUM GROWTH - Gross written premiums increased by 31.8% to $492.6 mln, driven by growth in casualty and crop insurance products

  • INVESTMENT INCOME - Net investment income rose 41.3% to $16.0 mln, primarily due to higher yields and increased investment balances

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Gross written premiums

$492.63 mln

Q4 Adjusted EPS

Beat

$2.24

$2.09 (8 Analysts)

Q4 EPS

$2.06

Q4 Adjusted Net Income

Beat

$61.12 mln

$57.21 mln (7 Analysts)

Q4 Net Income

$56.17 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the property & casualty insurance peer group is "buy"

  • Wall Street's median 12-month price target for Palomar Holdings Inc is $168.00, about 30% above its February 10 closing price of $129.25

  • The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release: ID:nGNXqPMlS

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10